Institutional members access full text with Ovid®

Kinase gene haplotypes and genegene interactions in the RasRafMAPK signaling pathway: association with antidepressant remission

Wang, Cong-jiea*; Zhang, Zhi-junb*; Xu, Zhib; Shi, Yan-yanc; Pu, Meng-jiab; Zheng, Zhia; Wang, Xiu-zhena; Zhang, Yu-meid; Li, Ling-jiange

International Clinical Psychopharmacology: September 2013 - Volume 28 - Issue 5 - p 245–254
doi: 10.1097/YIC.0b013e328362c89f
Original Articles

Signal transduction has been reported to be involved in antidepressant treatment outcomes; however, its mechanisms remain unclear. The aims of this study were to explore the associations between antidepressant remission and single nucleotide polymorphisms (SNPs), haplotypes, and gene–gene interactions in the Ras–Raf–MAPK intracellular signaling pathway. A total of 302 inpatients with major depressive disorder (DSM-IV Axis I) were assessed using the 17-item Hamilton Depression Rating Scale before and after 8 weeks of antidepressant treatment to determine the remission rate in the samples. Twenty-four SNPs at five kinase genes (Ras–Raf–MEK–ERK–RSK), which are a part of the Ras–Raf–MAPK signaling pathway, were identified to investigate a genetic association with antidepressant drug outcome. Correlations between 24 SNPs at the five kinase genes in the Ras–Raf–MAPK signaling pathway and antidepressant drug outcome were not found. The percentage of the CCAGA haplotype that RSK(2/3/4)–RSKL(1/2) gene loci SNPs constructed was markedly lower in the remitter group when compared with the nonremitter group in female depressed patients (P=0.04), whereas the proportion of AAAGGG haplotype that RSK(2/3/4)–RSKL(1/2) gene loci SNPs constructed in the remitter group was significantly greater than that in the nonremitter group in male patients (P=0.02). In addition, MEK1 (rs28730804) and RSK3 (rs2229712) in the Ras–Raf–MAPK signaling pathway showed a gene–gene interaction that affected antidepressant drug outcome in female depressed patients (P=0.041). Although this study did not find that SNPs at the five kinase genes in the Ras–Raf–MAPK signaling pathway are important markers for antidepressant outcome, certain haplotypes that SNPs at the RSK(2/3/4)–RSKL(1/2) gene constructed may be important markers for antidepressant drug efficacy. We observed a gene–gene interaction in this signaling pathway that influenced antidepressant efficacy in female depressed patients. Therefore, it is likely that in female depressed patients, different haplotypes and gene–gene interaction in the Ras–Raf–MAPK signaling pathway are involved in mediating the pharmacological action of an antidepressant, and eventually influence antidepressant efficacy.

aDepartment of Psychiatry, Huai’an No. 3 People’s Hospital, Huai’an

bDepartment of Neuropsychiatry, Affiliated ZhongDa Hospital and Neuropsychiatric Research Institute, Southeast University

cDepartment of Psychiatry, Affiliated Brain Hospital, Nanjing Medical University, Nanjing

dDepartment of Psychiatry, Yangzhou Wutaishan Hospital, Yangzhou

eMental Health Institute, The Second Xiangya Hospital, Central South University, Changsha, China

*Cong-jie Wang and Zhi-jun Zhang contributed equally to the writing of this article.

Correspondence to Cong-jie Wang, MSc, Department of Psychiatry, Huai’an No. 3 People’s Hospital, No. 272 West Huaihai Road, Huai’an 223001, Jiangsu Province, China Tel: +86 517 8366 4273; fax: +86 517 8364 1525; e-mail:

Received August 29, 2012

Accepted April 30, 2013

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins